Max Robotics — Global Service Robot Directory + US Certification

About

Fabio Manferrari is a leading figure in urologic oncology, with a focused expertise in the surgical management of localized renal masses. His primary research centers on optimizing outcomes for patients undergoing partial nephrectomy (PN), particularly through the development of predictive tools that enhance surgical decision-making. Manferrari’s major contribution is the creation of a clinical nomogram to predict the "trifecta" of outcomes—negative surgical margins, minimal complications, and warm ischemia time under 25 minutes—after open, laparoscopic, and robotic PN. This work, published in 2020 and cited 53 times, directly impacts patient counseling and surgical planning. Beyond renal surgery, Manferrari has advanced the safety of minimally invasive procedures through a comprehensive review of laparoscopic entry methods, co-authoring both a Spanish and English version that have collectively garnered 34 citations. His innovative spirit is further evidenced by a patent for a laparoscopic surgical instrument designed to replicate robotic dexterity at a lower cost. With a career dedicated to refining surgical techniques and improving patient prognoses, Manferrari’s research bridges the gap between clinical prediction and operative precision.